Lloyd Advisory Services’s GSK GSK Stock Holding History

Lloyd Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157	Sell	3 -33	-92%	-$1.75K	﹤0.01%	615
2026 Q1	$1.99K	Sell	36 -2,689	-99%	-$146K	﹤0.01%	661
2025 Q4	$134K	Buy	+2,725	New	+$127K	0.05%	153
2020 Q4	–	Sell	-2,770	Closed	-$130K	–	370
2020 Q3	$130K	Sell	2,770 -1,416	-34%	-$70.9K	0.08%	65
2020 Q2	$213K	Sell	4,186 -449	-10%	-$23K	0.13%	55
2020 Q1	$220K	Sell	4,635 -1,413	-23%	-$75.4K	0.16%	44
2019 Q4	$355K	Buy	+6,048	New	+$336K	0.32%	43

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lloyd Advisory Services's GSK Position: Q2 2026 in Review

Lloyd Advisory Services reduced its GSK (GSK) stake by 92% in Q2 2026, selling an estimated $1.75K and leaving 3 shares worth $157. The position accounts for ﹤0.01% of the portfolio, ranked #615.

Lloyd Advisory Services first reported a position in GSK in Q4 2019 and has held it in 7 quarters since. The position peaked at $355K in Q4 2019. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Lloyd Advisory Services held 3 shares of GSK worth $157 as of Q2 2026.
Lloyd Advisory Services sold 33 GSK shares in Q2 2026, an estimated $1.75K.
GSK made up ﹤0.01% of Lloyd Advisory Services's portfolio in Q2 2026, its #615 holding.
Lloyd Advisory Services first reported a position in GSK in Q4 2019 and has held it in 7 quarters since.
Lloyd Advisory Services's GSK position peaked at $355K in Q4 2019.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.